Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Anthraquinone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | CDC25B | P30305 | 2/20 | 0.71 |
| ▸ | MAOA | P21397 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | APAF1 | O14727 | 2/20 | 0.58 |
| ▸ | TDP2 | O95551 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | S100A4 | P26447 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | CES2 | O00748 | 1/20 | 0.58 |
| ▸ | TERT | O14746 | 1/20 | 0.58 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.58 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anthraquinone SCHEMBL2478622 | 0.84 | MEN1 (0.86) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL28117181 | 0.84 | MEN1 (0.86) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL14943 | 0.84 | MEN1 (1.00) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL29358690 | 0.84 | MEN1 (1.00) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL1901249 | 0.84 | MEN1 (1.00) | MEN1KMT2ACDC25BMAOARAB9A | |
| Naphthoquinone SCHEMBL5157257 | 0.81 | IDO1 (0.70) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL1405500 | 0.81 | MEN1 (0.52) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL6415478 | 0.81 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL10905960 | 0.81 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL11300863 | 0.81 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015743-A1 | MEDIATED HYDROGEN ANODE FOR USE IN REDUCTIVE ELECTROSYNTHESIS | WISCONSIN ALUMNI RES FOUND (US) | 2026-01-15 | — | — | US | disclosed |
| US-11931928-B2 | Continuous strand superabsorbent polymerization | EVONIK SUPERABSORBER LLC (US) | 2024-03-19 | — | — | US | disclosed |
| CN-108250458-B | Continuous strand superabsorbent polymer | 赢创超级吸收剂有限责任公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-108250458-A | Continuous threadiness superabsorbent polymer | 赢创有限公司 | 2018-07-06 | — | — | CN | disclosed |
| US-20180186042-A1 | Continuous Strand Superabsorbent Polymerization | EVONIK SUPERABSORBER LLC | 2018-07-05 | — | — | US | disclosed |
| EP-3342787-A1 | CONTINUOUS STRAND SUPERABSORBENT POLYMERIZATION | Evonik Corporation (US) | 2018-07-04 | — | — | EP | disclosed |
| EP-1328952-B1 | POWDER FOR CAPACITOR, SINTERED BODY AND CAPACITOR USING THE SINTERED BODY | SHOWA DENKO KK (JP) | 2008-12-03 | — | — | EP | disclosed |
| CN-100440400-C | Powder for capacitor, sintered body and capacitor using the sintered body | SHOWA DENKO KK (JP) | 2008-12-03 | — | — | CN | disclosed |
| US-7192465-B2 | Niobium powder for capacitor, sintered body thereof and capacitor using the sintered body | SHOWA DENKO K.K. (JP) | 2007-03-20 | — | — | US | disclosed |
| EP-1264321-B1 | NIOBIUM POWDER FOR CAPACITOR, SINTERED BODY THEREOF AND CAPACITOR USING THE SINTERED BODY | SHOWA DENKO KK (JP) | 2006-08-16 | — | — | EP | disclosed |
| EP-1264321-A4 | NIOBIUM POWDER FOR CAPACITOR, SINTERED BODY THEREOF AND CAPACITOR USING THE SINTERED BODY | SHOWA DENKO KK (JP) | 2004-03-17 | — | — | EP | disclosed |
| US-20040042154-A1 | Powder for capacitor, sintered body and capacitor using the sintered body | SHOWA DENKO K.K. (JP) | 2004-03-04 | — | — | US | disclosed |
| CN-1471717-A | Powder for capacitor, sintered body and capacitor using the sintered body | �Ѻ͵繤��ʽ���� | 2004-01-28 | — | — | CN | disclosed |
| EP-1328952-A2 | POWDER FOR CAPACITOR, SINTERED BODY AND CAPACITOR USING THE SINTERED BODY | Showa Denko K.K. (JP) | 2003-07-23 | — | — | EP | disclosed |
| US-20030100185-A1 | Niobium powder for capacitor, sintered body thereof and capacitor using the sintered body | SHOWA DENKO K.K. (JP) | 2003-05-29 | — | — | US | disclosed |
| EP-1264321-A1 | NIOBIUM POWDER FOR CAPACITOR, SINTERED BODY THEREOF AND CAPACITOR USING THE SINTERED BODY | Showa Denko K.K. (JP) | 2002-12-11 | — | — | EP | disclosed |
| WO-2002045108-A1 | NIOBIUM POWDER FOR CAPACITOR, SINTERED BODY THEREOF AND CAPACITOR USING THE SINTERED BODY | SHOWA DENKO K.K. (JP) | 2002-06-06 | — | — | WO | disclosed |
| WO-2002035563-A2 | POWDER FOR CAPACITOR, SINTERED BODY AND CAPACITOR USING THE SINTERED BODY | SHOWA DENKO K.K. (JP) | 2002-05-02 | — | — | WO | disclosed |
| US-4605705-A | DIISOPROPYL XANTHOGEN DISULFIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-08-12 | — | — | US | disclosed |
| EP-0175245-A2 | Heat resistant sulfur-modified polychloroprene copolymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-03-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015743-A1 | MEDIATED HYDROGEN ANODE FOR USE IN REDUCTIVE ELECTROSYNTHESIS | HAO2, HACL2, HVCN1 | MEN1 1589/4885KMT2A 1868/4885CDC25B 321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.